Manganese superoxide dismutase gene polymorphisms in psoriatic arthritis

Jeng-Hsien Yen1, Wen-Chun Tsai, Chia-Hui Lin

  • 1Division of Rheumatology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan. jehsye@kmu.edu.tw

Disease Markers
|July 23, 2004
PubMed

Insights

Manganese superoxide dismutase (MnSOD) gene 1183C polymorphisms may increase the risk of developing psoriatic arthritis. This study found a higher frequency of the MnSOD 1183C variant in patients compared to healthy individuals.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Psoriatic arthritis is a chronic inflammatory condition.
  • The genetic factors contributing to psoriatic arthritis susceptibility are not fully understood.
  • Superoxide dismutase enzymes play a role in cellular defense against oxidative stress.

Purpose of the Study:

  • To investigate the association between manganese superoxide dismutase (MnSOD) gene polymorphisms and psoriatic arthritis risk.
  • To determine if specific MnSOD genotypes or phenotypes are more prevalent in psoriatic arthritis patients.

Main Methods:

  • Polymerase chain reaction/restriction fragment length polymorphisms (PCR/RFLP) was used to analyze MnSOD gene polymorphisms.
  • The study included 52 patients diagnosed with psoriatic arthritis and 90 healthy controls.
  • Genotype and phenotype frequencies of MnSOD 1183C/T were compared between the patient and control groups.

Main Results:

  • The genotype frequency of MnSOD 1183C/T was significantly higher in psoriatic arthritis patients compared to controls.
  • Conversely, the MnSOD 1183T/T genotype frequency was significantly lower in patients.
  • The phenotype frequency of MnSOD 1183C was significantly increased in psoriatic arthritis patients.

Conclusions:

  • MnSOD 1183C polymorphisms may be a contributing factor to the development of psoriatic arthritis.
  • These findings suggest a potential role for oxidative stress pathways in psoriatic arthritis pathogenesis.
  • Further research is warranted to elucidate the precise mechanisms linking MnSOD gene variations to psoriatic arthritis.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...